RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 156 filers reported holding RELAY THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,812 | -53.3% | 215,469 | -30.3% | 0.00% | -50.0% |
| Q2 2023 | $3,882 | +21.2% | 309,179 | +59.0% | 0.00% | +100.0% |
| Q1 2023 | $3,203 | -21.1% | 194,470 | -28.5% | 0.00% | -50.0% |
| Q4 2022 | $4,061 | -99.9% | 271,839 | +81.0% | 0.00% | -50.0% |
| Q3 2022 | $3,361,000 | +187.5% | 150,211 | +115.2% | 0.00% | +300.0% |
| Q2 2022 | $1,169,000 | -48.7% | 69,807 | -8.2% | 0.00% | -50.0% |
| Q1 2022 | $2,277,000 | – | 76,068 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 10,551,115 | $438,504,000 | 37.66% |
| TRV GP IV, LLC | 2,811,197 | $116,833,000 | 37.48% |
| Foresite Capital Management V, LLC | 400,000 | $16,624,000 | 12.31% |
| Foresite Capital Management IV, LLC | 2,139,380 | $88,913,000 | 9.66% |
| EcoR1 Capital, LLC | 3,200,649 | $133,019,000 | 7.15% |
| BVF INC/IL | 3,073,147 | $127,720,000 | 5.02% |
| Casdin Capital, LLC | 3,808,894 | $158,298,000 | 4.69% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $1,159,730,000 | 4.67% |
| Grace Capital | 164,389 | $6,832,000 | 4.32% |
| Alphabet Inc. | 1,801,490 | $74,870,000 | 3.59% |